ALL4LIVER
The ALL4LIVER Grant funds global community projects (outside the US) that advance education, testing, care linkage, and advocacy to help eliminate viral hepatitis as a public health threat by 2030.
Funder: Gilead Sciences
Due Dates (Anticipated): September 2027 (Application deadline, projected)
Funding Amounts: Award size and duration vary by project scope, scale, and country; up to 10% of budget may be dedicated to impact reporting.
Summary: Supports global (excluding US) community initiatives to enhance education, awareness, and action to eliminate viral hepatitis as a public health threat by 2030.
Description
The ALL4LIVER Grant, established by Gilead Sciences, is a biennial global initiative (excluding the United States) aimed at supporting local communities to enhance education, awareness, and collective action around viral hepatitis. The program aligns with the World Health Organization’s goal to eliminate viral hepatitis as a public health threat by 2030 by empowering communities, strengthening healthcare systems, and improving access to essential services. Projects should focus on testing, linkage to care, and advocacy to prioritize viral hepatitis on public health agendas.
